<PAGE>
FILED SOLELY TO COMPLY WITH SEC FINANCIAL DATA SCHEDULE
REPORTING REQUIREMENTS
FORM 10-Q/A
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
QUARTERLY REPORT UNDER SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the Quarter Ended Commission File Number: 1-10432
March 31, 1995
ROBERTS PHARMACEUTICAL CORPORATION
(Exact name of registrant as specified in its charter)
NEW JERSEY 22-2429994
(State or other jurisdiction of (I.R.S. Employer)
incorporation or organization) Identification No.)
MERIDIAN CENTER II 07724
4 INDUSTRIAL WAY WEST (Zip Code)
EATONTOWN, NEW JERSEY
(Address of principal executive offices)
(Registrant's telephone number, including area code:
(908) 389-1182)
Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.
Yes X No
---- ----
Class Outstanding Shares at
April 27, 1995
Common Stock 18,531,393
<PAGE>
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this amendment to be signed on its behalf by the
undersigned, thereunto duly authorized.
ROBERTS PHARMACEUTICAL CORPORATION
Date: 7/12/95 /s/ Anthony P. Maris
-----------------------------------
Anthony P. Maris
Vice President and Treasurer
Date: 7/12/95 /s/ Anthony P. Maris
-----------------------------------
Anthony P. Maris
Chief Accounting Officer
<PAGE>
ROBERTS PHARMACEUTICAL CORPORATION
INDEX
Page
Part II
Item 6 -- Exhibit 27 Attached 3
Signatures
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM FORM 10-Q
FOR THE QUARTER ENDED MARCH 31, 1995 AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> DEC-31-1995
<PERIOD-START> JAN-01-1995
<PERIOD-END> MAR-31-1995
<CASH> 11,323
<SECURITIES> 23,793
<RECEIVABLES> 21,790<F1>
<ALLOWANCES> 0
<INVENTORY> 24,802<F2>
<CURRENT-ASSETS> 85,222
<PP&E> 16,920
<DEPRECIATION> 0
<TOTAL-ASSETS> 347,141
<CURRENT-LIABILITIES> 51,078
<BONDS> 36,850
<COMMON> 189
0
0
<OTHER-SE> 258,276
<TOTAL-LIABILITY-AND-EQUITY> 347,141
<SALES> 18,363
<TOTAL-REVENUES> 20,229
<CGS> 6,596
<TOTAL-COSTS> 7,832
<OTHER-EXPENSES> 2,034
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 689
<INCOME-PRETAX> (1,958)
<INCOME-TAX> (764)
<INCOME-CONTINUING> (1,194)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (1,194)
<EPS-PRIMARY> (.06)
<EPS-DILUTED> (.06)
<FN>
<F1>INCLUDES SHAREHOLDER RECEIVABLE OF $1,536.
<F2>INCLUDES RAW MATERIAL INVENTORY OF $3,362.
</FN>
</TABLE>
